Analyst desks were busy this week. Three names stood out for contrasting reasons.
First Solar saw a recommendation removed from consensus. The $25 billion solar manufacturer carries 8.2% short interest. Analysts have been wary of policy risk around clean energy subsidies. The average target price sits at $243.
Applied Materials attracted a fresh new recommendation. The $346 billion chipmaker now has a consensus target of $503. That is a meaningful premium to the prior average of $451. Semiconductor equipment stocks are rebounding on easing US-China trade tensions.
The week's clearest upgrade came in utilities. Consolidated Edison was moved up to a buy-equivalent rating. The $39 billion New York utility benefits from stable regulated earnings. Analysts see it as a defensive play in a choppy macro environment.
Pfizer got a target price lift despite lingering doubts about its post-pandemic pipeline. The consensus target nudged up to $29.19. That still implies a cautious stance. Ten analysts rate it a sell or equivalent.
Fair Isaac and both saw modest target cuts. Credit data names are feeling pressure as loan volumes slow.
This is not financial advice.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
